Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylere®) for Helicobacter pylori eradication

被引:3
|
作者
Castro-Fernandez, Manuel [1 ]
Marques-Ruiz, Alberto [1 ]
Camara-Baena, Sergio [1 ]
Grande-Santamaria, Lourdes [1 ]
机构
[1] Hosp Univ Valme, Unidad Gest Cin Enfermedades Digest, Seville, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2019年 / 42卷 / 07期
关键词
TRIPLE-THERAPY; CLARITHROMYCIN; METRONIDAZOLE;
D O I
10.1016/j.gastrohep.2019.01.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:459 / 460
页数:2
相关论文
共 50 条
  • [41] Bismuth-Based First-Line Therapy for Helicobacter pylori Eradication in Type 2 Diabetes Mellitus Patients
    Demir, Mehmet
    Gokturk, Savas
    Ozturk, Nevin Akcaer
    Serin, Ender
    Yilmaz, Ugur
    DIGESTION, 2010, 82 (01) : 47 - 53
  • [42] Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
    Bang, Chang Seok
    Lim, Hyun
    Jeong, Hae Min
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    GUT MICROBES, 2020, 11 (05) : 1314 - 1323
  • [43] HELICOBACTER PYLORI ERADICATION A new, single-capsule bismuth-containing quadruple therapy
    Gisbert, Javier P.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (06) : 307 - 309
  • [44] Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?
    Liou, Jyh-Ming
    Lin, Jaw-Town
    Wu, Ming-Shiang
    GASTROENTEROLOGY, 2017, 152 (01) : 301 - 302
  • [45] Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication
    Ozturk, Oguzhan
    Doganay, Levent
    Colak, Yasar
    Enc, Feruze Yilmaz
    Ulasoglu, Celal
    Ozdil, Kamil
    Tuncer, Ilyas
    ARAB JOURNAL OF GASTROENTEROLOGY, 2017, 18 (02) : 62 - 67
  • [46] Bismuth-Containing Quadruple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
    Lee, Byoung Hwan
    Kim, Nayoung
    Hwang, Tae Jun
    Lee, Sang Hyub
    Park, Young Soo
    Hwang, Jin-Hyeok
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Lee, Dong Hoo
    Jung, Hyun Chae
    Song, In Sung
    HELICOBACTER, 2010, 15 (01) : 38 - 45
  • [47] Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
    Jheng, Guang-Hong
    Wu, I-Chen
    Shih, Hsiang-Yao
    Wu, Meng-Chieh
    Kuo, Fu-Chen
    Hu, Huang-Ming
    Liu, Chung-Jung
    Hsu, Wen-Hung
    Hu, Chi-Tan
    Bair, Ming-Jong
    Kuo, Chao-Hung
    Wu, Deng-Chyang
    Hsu, Ping-, I
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [48] High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
    Sun, Qinjuan
    Liang, Xiao
    Zheng, Qing
    Liu, Wenzhong
    Xiao, Shudong
    Gu, Weiqi
    Lu, Hong
    HELICOBACTER, 2010, 15 (03) : 233 - 238
  • [49] Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance
    Zheng, Qing
    Chen, Wan Jun
    Lu, Hong
    Sun, Qin Juan
    Xiao, Shu Dong
    JOURNAL OF DIGESTIVE DISEASES, 2010, 11 (05) : 313 - 318
  • [50] A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial
    Ma, Junling
    Liu, Weidong
    Zhang, Lian
    Pan, Kaifeng
    Zhao, Hongjun
    Zhou, Tong
    Winawer, Sidney
    Zauber, Ann
    Classen, Meinhard
    You, Weicheng
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (05) : 597 - 601